New pharma products in the market
The Pharmaceutical Division of SMC Enterprise Ltd started its journey in August 2017 with the key objective of “No one should suffer, especially the less-privileged due to lack of affordable quality medicine.” The slogan that will drive SMC’s pharmaceutical business is “providing quality medicine for all” irrespective of socio-economic status and ability to pay. It promotes 18 products in the market which includes anti-ulcerant, NSAIDs, anti-histamine, anti-asthmatic, anti-spasmodic and mineral supplement. These drugs belong to both the OTC category as well as the selective therapeutic class. In July 2018, SMC Pharmaceutical Division launched three new products:
● SMC Zinc Syrup (To enhance growth, develop brain function and improve immune system)
● Moticare (For the treatment of nausea, vomiting, gas and bloating, postprandial fullness, GERD, heartburn, etc.)
● Kofmelt Syrup (For the treatment of cough with mucus)
With the philosophy “profit must primarily contribute to social betterment” our pharma division is taking all initiatives to fulfill the objective.
